Editorial
doi: 10.3350/cmh.2012.18.4.357.
Epub 2012 Dec 21.
Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
- PMID: 23323250
- PMCID: PMC3540371
- DOI: 10.3350/cmh.2012.18.4.357
Item in Clipboard
Editorial
Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
Clin Mol Hepatol.
2012 Dec.
No abstract available
Keywords: Bilirubin; Nonalcoholic fatty liver disease.
Conflict of interest statement
The author has no conflicts to disclose.
Comment on
-
Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.Clin Mol Hepatol. 2012 Dec;18(4):383-90. doi: 10.3350/cmh.2012.18.4.383. Epub 2012 Dec 21. Clin Mol Hepatol. 2012. PMID: 23323254 Free PMC article.
Similar articles
-
Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.Clin Mol Hepatol. 2012 Dec;18(4):383-90. doi: 10.3350/cmh.2012.18.4.383. Epub 2012 Dec 21. Clin Mol Hepatol. 2012. PMID: 23323254 Free PMC article.
-
Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease.J Biol Regul Homeost Agents. 2011 Jan-Mar;25(1):47-56. J Biol Regul Homeost Agents. 2011. PMID: 21382273
-
Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease.Pediatrics. 2009 Dec;124(6):e1221-7. doi: 10.1542/peds.2008-3087. Pediatrics. 2009. PMID: 19948621
-
The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.Clin Liver Dis. 2012 Aug;16(3):599-613. doi: 10.1016/j.cld.2012.05.008. Epub 2012 Jul 3. Clin Liver Dis. 2012. PMID: 22824483 Review.
-
Can NASH be diagnosed, graded, and staged noninvasively?Clin Liver Dis. 2012 Aug;16(3):567-85. doi: 10.1016/j.cld.2012.05.001. Epub 2012 Jun 26. Clin Liver Dis. 2012. PMID: 22824481 Free PMC article. Review.
Cited by
-
Biliverdin reductase and bilirubin in hepatic disease.Am J Physiol Gastrointest Liver Physiol. 2018 Jun 1;314(6):G668-G676. doi: 10.1152/ajpgi.00026.2018. Epub 2018 Mar 1. Am J Physiol Gastrointest Liver Physiol. 2018. PMID: 29494209 Free PMC article. Review.
-
Bilirubin in the Liver-Gut Signaling Axis.Trends Endocrinol Metab. 2018 Mar;29(3):140-150. doi: 10.1016/j.tem.2018.01.002. Epub 2018 Feb 3. Trends Endocrinol Metab. 2018. PMID: 29409713 Free PMC article. Review.
-
The Role of Bilirubin and the Other "Yellow Players" in Neurodegenerative Diseases.Antioxidants (Basel). 2020 Sep 22;9(9):900. doi: 10.3390/antiox9090900. Antioxidants (Basel). 2020. PMID: 32971784 Free PMC article. Review.
-
Bilirubin, a new therapeutic for kidney transplant?Transplant Rev (Orlando). 2018 Oct;32(4):234-240. doi: 10.1016/j.trre.2018.06.003. Epub 2018 Jun 28. Transplant Rev (Orlando). 2018. PMID: 29983261 Free PMC article. Review.
-
Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes.Drug Des Devel Ther. 2017 Dec 5;11:3449-3460. doi: 10.2147/DDDT.S150187. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29255346 Free PMC article.
References
-
- Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–438. - PubMed
-
- Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis. 2011;12:125–130. - PubMed
-
- Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–1850. - PubMed
-
- Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–121. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
